Prevalence of Chronic Obstructive Pulmonary Disease in an Urban Area. Changes in COPD Ten Years on

References

• Soriano JB, Kendrick PJ, Paulson KR; GBD Chronic Respiratory Disease Collaborators. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. 2020;8(6):585–596. doi:10.1016/S2213-2600(20)30105-3
   PubMed Web of Science ®Google Scholar
• Blanco I, Diego I, Bueno P, Casas-Maldonado F, Miravitlles M. Geographic distribution of COPD prevalence in the world displayed by Geographic Information System maps. Eur Respir J. 2019;54(1):1900610. doi:10.1183/13993003.00610-2019
   PubMed Web of Science ®Google Scholar
• Menezes AMB, Perez-Padilla R, Jardim JB, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet. 2005;366(9500):1875–1881. doi:10.1016/S0140-6736(05)67632-5
   PubMed Web of Science ®Google Scholar
• Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study. Lancet. 2007;370(9589):741–750. doi:10.1016/S0140-6736(07)61377-4
   PubMed Web of Science ®Google Scholar
• Sobradillo V, Miravitlles M, Jiménez CA, et al. Epidemiological study of chronic obstructive pulmonary disease in Spain (IBERPOC): prevalence of chronic respiratory symptoms and airflow limitation. Arch Bronconeumol. 1999;35(4):159–166. doi:10.1016/S0300-2896(15)30272-6
   PubMedGoogle Scholar
• Miravitlles M, Soriano JB, Garcia-Rio F, et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax. 2009;64(10):863–868. doi:10.1136/thx.2009.115725
   PubMed Web of Science ®Google Scholar
• Soriano JB, Alfageme I, Miravitlles M, et al. Prevalence and determinants of COPD in Spain: EPISCAN II. Arch Bronconeumol. 2021;57(1):61–69. doi:10.1016/j.arbres.2020.07.024
   PubMed Web of Science ®Google Scholar
• Ntritsos G, Franek J, Belbasis L, et al. Gender-specific estimates of COPD prevalence: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2018;13:1507–1514. doi:10.2147/COPD.S146390
   PubMed Web of Science ®Google Scholar
• Ancochea J, Badiola C, Duran-Tauleria E, et al.. The EPI-SCAN Survey to Assess the Prevalence of Chronic Obstructive Pulmonary Disease in Spanish 40-to-80-Year-Olds: Protocol Summary Arch Bronconeumol. 2009;45(1):41–47. doi:10.1016/j.arbres.2008.06.001
   PubMed Web of Science ®Google Scholar
• Alfageme I, de Lucas P, Ancochea J, et al. 10 years after EPISCAN: a new study on the prevalence of COPD in Spain -A summary of the EPISCAN II protocol. Arch Bronconeumol. 2019;55(1):38–47. doi:10.1016/j.arbres.2018.05.011
   PubMed Web of Science ®Google Scholar
• Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6):532–555. doi:10.1164/rccm.200703-456SO
   PubMed Web of Science ®Google Scholar
• Pellegrino R. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948–968. doi:10.1183/09031936.05.00035205
   PubMed Web of Science ®Google Scholar
• Swanney MP, Ruppel G, Enright PL, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax. 2008;63(12):1046–1051. doi:10.1136/thx.2008.098483
   PubMed Web of Science ®Google Scholar
• STROBE. Strengthening the reporting of observational studies in epidemiology. Available at: https://www.strobe-statement.org/. Accessed September 12, 2022.
   Google Scholar
• Sokal RR, Rohlf FJ. Biometry: The Principles and Practice of Statistics in Biological Research. 3rd ed. New York: W.H. Freeman and Co; 1995
   Google Scholar
• Soriano JB, Ancochea J, Miravitlles M, et al. Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997–2007. Eur Respir J. 2010;36(4):758–765. doi:10.1183/09031936.00138409
   PubMed Web of Science ®Google Scholar
• Alabi FO, Alkhateeb HA, DeBarros KM, et al. The heterogeneity of COPD patients in a community-based practice and the inadequacy of the global initiative for chronic obstructive lung disease criteria: a real-world experience. Chronic Obstr Pulm Dis J COPD Found. 2021;8(3):396–407. doi:10.15326/jcopdf.2021.0229
   PubMed Web of Science ®Google Scholar
• Liu S, Zhou Y, Liu S, et al. Clinical impact of the lower limit of normal of FEV1/FVC on detecting chronic obstructive pulmonary disease: a follow-up study based on cross-sectional data. Respir Med. 2018;139:27–33. doi:10.1016/j.rmed.2018.04.011
   PubMed Web of Science ®Google Scholar
• Rabe KF, Watz H. Chronic obstructive pulmonary disease. Lancet. 2017;389(10082):1931–1940. doi:10.1016/S0140-6736(17)31222-9
   PubMed Web of Science ®Google Scholar
• Raherison C, Girodet P-O. Epidemiology of COPD. Eur Respir Rev. 2009;18(114):213–221. doi:10.1183/09059180.00003609
   PubMedGoogle Scholar
• Boldo E, Querol X. [New European policies for air pollution control: A step forward in improving public health?].Gac Sanit. 2014;28(4):263–266. doi:10.1016/j.gaceta.2014.04.003
   PubMed Web of Science ®Google Scholar
• Ecologists in Action, Air quality in the city of Madrid; 2017. Available at: https://www.ecologistasenaccion.org/35593/2017-aumenta-la-contaminacion-del-aire-madrid/. Accessed September 12, 2022.
   Google Scholar
• Report of the General Directorate of Quality, Control and Environmental Evaluation. Department of Air Quality. Air quality. Daily data years 2001 to 2021. Available at: https://www.mambiente.madrid.es/opencms/calaire/Publicaciones/memoria_2007.html. Accessed September 12, 2022.
   Google Scholar
• Feliu A, Martínez C, Fernández E. Lights and shadows for public health: A critical analysis of the tobacco legislation in Spain. Gac Sanit. 2022;36(1):48–52. doi:10.1016/j.gaceta.2021.07.001
   PubMed Web of Science ®Google Scholar
• WHO global report on trends in prevalence of tobacco use 2000–2025, Tercera edición. Geneva, Switzerland: World Health Organization; 2019. ISBN: 978-92-4-000003-2.
   Google Scholar
• Epidemiology Service. Results of the Comprehensive Smoking Surveillance System (VITa). Report 2021. Available from: https://www.comunidad.madrid/sites/default/files/doc/sanidad/epid/informe_tabaco_vita_2021.pdf. Accessed September 12, 2022.
   Google Scholar
• Alonso T, Sobradillo P, de Torres JP. Chronic obstructive pulmonary disease in Women. Is it Different? Arch Bronconeumol. 2017;53(4):222–227. doi:10.1016/j.arbres.2016.10.008
   PubMed Web of Science ®Google Scholar
• Jenkins C. Differences between men and women with chronic obstructive pulmonary disease. Clin Chest Med. 2021;42(3):443–456. doi:10.1016/j.ccm.2021.06.001
   PubMed Web of Science ®Google Scholar
• Ho T, Cusack RP, Chaudhary N, Satia I, Kurmi OP. Under- and over-diagnosis of COPD: a global perspective. Breathe. 2019;15(1):24–35. doi:10.1183/20734735.0346-2018
   Web of Science ®Google Scholar
• Soriano JB, Calle M, Montemayor T, Álvarez-Sala JL, Ruiz-Manzano J, Miravitlles M. The General Public's Knowledge of Chronic Obstructive Pulmonary Disease and Its Determinants: Current Situation and Recent Changes. Arch Bronconeumol. 2012;48(9):308–315. doi:10.1016/j.arbres.2012.04.008
   PubMed Web of Science ®Google Scholar
• Jia G, Lu M, Wu R, Chen Y, Yao W. Gender difference on the knowledge, attitude, and practice of COPD diagnosis and treatment: a national, multicenter, cross-sectional survey in China. Int J Chron Obstruct Pulmon Dis. 2018;13:3269–3280. doi:10.2147/COPD.S176173
   PubMed Web of Science ®Google Scholar
• Cabrera López C, Juliá Serdá G, Cabrera Lacalzada C, et al. Prevalence of Chronic Obstructive Pulmonary Disease in the Canary Islands. Archivos de bronconeumologia. 2014;50(7):272–277. doi:10.1016/j.arbres.2013.12.006
   PubMed Web of Science ®Google Scholar
• Keogh E, Mark Williams E. Managing malnutrition in COPD: a review. Respir Med. 2021;176:106248. doi:10.1016/j.rmed.2020.106248
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Soler-Cataluña JJ, Calle M, et al. Spanish Guidelines for Management of Chronic Obstructive Pulmonary Disease (GesEPOC) 2017. Pharmacological Treatment of Stable Phase Arch Bronconeumol. 2017;53(6):324–335. doi:10.1016/j.arbres.2017.03.018
   PubMed Web of Science ®Google Scholar
• Miller MR. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.00034805
   PubMed Web of Science ®Google Scholar
• García-Río F, Calle M, Burgos F, et al. Spirometry Arch Bronconeumol. 2013;49(9):388–401. doi:10.1016/j.arbres.2013.04.001
   PubMed Web of Science ®Google Scholar
• Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault J-C. Lung volumes and forced ventilatory flows. Eur Respir J. 1993;6(16):5–40. doi:10.1183/09041950.005s1693
   PubMed Web of Science ®Google Scholar
• Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324–1343. doi:10.1183/09031936.00080312
   PubMed Web of Science ®Google Scholar
• Celli BR, MacNee W, Agusti A, et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23(6):932–946. doi:10.1183/09031936.04.00014304
   PubMed Web of Science ®Google Scholar
• Brusasco V. Coming together: the ATS/ERS consensus on clinical pulmonary function testing. Eur Respir J. 2005;26(1):1–2. doi:10.1183/09031936.05.00034205
   PubMed Web of Science ®Google Scholar